Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial
DiscussionPrevious studies have demonstrated the safety and feasibility of D2 + CME for locally advanced gastric cancer; however, there is still a lack of evidence to support its therapeutic effect. Thus, we performed this randomized trial to investigate whether D2 + CME can improve oncologic outcomes of patients with locally advanced gastric cancer. The findings fro m this trial may potentially optimize the surgical procedure and may improve the prognosis of patients with locally advanced gastric cancer.Trial registrationClinicalTrials.gov,NCT01978444. Registered on October 31, 2013.
Source: Trials - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Anesthesia | Anesthesiology | Cancer | Cancer & Oncology | Chemotherapy | China Health | Gastrectomy | Gastric (Stomach) Cancer | Gastroenterology | Hospitals | Laparoscopy | Research | Study